[Jin Wan Lin - Innovation] April 2026 Revenue 35 Million (Year-on-Year -15.5%)
Jin Wan Lin - Innovation (金萬林-創) reported April 2026 revenue of 34.751 million TWD, a decrease of 15.5% year-over-year. This suggests potential market headwinds or operational adjustments in the biotechnology and medical sector.
📋 Article Processing Timeline
- 📰 Published: April 1, 2026 at 09:00
- 🔍 Collected: May 12, 2026 at 08:00 (983h 0m after Published)
- 🤖 AI Analyzed: May 12, 2026 at 10:22 (2h 22m after Collected)
Jin Wan Lin - Innovation (Stock Code: 6645), a company specializing in the Biotechnology and Medical Industry, has released its revenue figures for April 2026. The company reported a monthly revenue of 34,751 thousand TWD, approximately 35 million TWD. This represents a year-over-year decrease of 15.5% compared to the same month in the previous year. The decline in revenue suggests potential market headwinds or operational adjustments within the biotechnology and medical sector for the company.